Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer.

Kang HG, Kim WJ, Kang HG, Chun KH, Kim SJ.

Mol Cancer Res. 2019 Dec 10. doi: 10.1158/1541-7786.MCR-19-0811. [Epub ahead of print]

PMID:
31822520
2.

Correction to: Post-translational modification of OCT4 in breast cancer tumorigenesis.

Cho Y, Kang HG, Kim SJ, Lee S, Jee S, Ahn SG, Kang MJ, Song JS, Chung JY, Yi EC, Chun KH.

Cell Death Differ. 2019 Oct 22. doi: 10.1038/s41418-019-0439-x. [Epub ahead of print]

PMID:
31641242
3.

CD200 Induces Epithelial-to-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma via β-Catenin-Mediated Nuclear Translocation.

Shin SP, Goh AR, Kang HG, Kim SJ, Kim JK, Kim KT, Lee JH, Bae YS, Jung YS, Lee SJ.

Cancers (Basel). 2019 Oct 17;11(10). pii: E1583. doi: 10.3390/cancers11101583.

4.

Heat Shock Factor 1 Predicts Poor Prognosis of Gastric Cancer.

Kim SJ, Lee SC, Kang HG, Gim J, Lee KH, Lee SH, Chun KH.

Yonsei Med J. 2018 Nov;59(9):1041-1048. doi: 10.3349/ymj.2018.59.9.1041.

5.

Post-translational modification of OCT4 in breast cancer tumorigenesis.

Cho Y, Kang HG, Kim SJ, Lee S, Jee S, Ahn SG, Kang MJ, Song JS, Chung JY, Yi EC, Chun KH.

Cell Death Differ. 2018 Nov;25(10):1781-1795. doi: 10.1038/s41418-018-0079-6. Epub 2018 Mar 6. Erratum in: Cell Death Differ. 2019 Oct 22;:.

6.

Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain.

Kang HG, Kim DH, Kim SJ, Cho Y, Jung J, Jang W, Chun KH.

Oncotarget. 2016 Oct 18;7(42):68229-68241. doi: 10.18632/oncotarget.11920.

7.

Ablation of human telomerase reverse transcriptase (hTERT) induces cellular senescence in gastric cancer through a galectin-3 dependent mechanism.

La SH, Kim SJ, Kang HG, Lee HW, Chun KH.

Oncotarget. 2016 Aug 30;7(35):57117-57130. doi: 10.18632/oncotarget.10986.

8.

Targeting the WEE1 kinase as a molecular targeted therapy for gastric cancer.

Kim HY, Cho Y, Kang H, Yim YS, Kim SJ, Song J, Chun KH.

Oncotarget. 2016 Aug 2;7(31):49902-49916. doi: 10.18632/oncotarget.10231.

9.

Arthroscopic Changes of the Biceps Pulley in Rotator Cuff Tear and Its Clinical Significance in Relation to Treatment.

Choi CH, Kim SS, Kim SJ, Lee JH.

Clin Orthop Surg. 2015 Sep;7(3):365-71. doi: 10.4055/cios.2015.7.3.365. Epub 2015 Aug 13.

10.

Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer.

Lee HW, Kim SJ, Choi IJ, Song J, Chun KH.

Clin Exp Metastasis. 2015 Aug;32(6):593-603. doi: 10.1007/s10585-015-9730-5. Epub 2015 Jul 2.

PMID:
26134677
11.

Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.

Cho Y, Lee HW, Kang HG, Kim HY, Kim SJ, Chun KH.

Oncotarget. 2015 Apr 20;6(11):8709-21.

12.

Galectin-3 activates PPARγ and supports white adipose tissue formation and high-fat diet-induced obesity.

Baek JH, Kim SJ, Kang HG, Lee HW, Kim JH, Hwang KA, Song J, Chun KH.

Endocrinology. 2015 Jan;156(1):147-56. doi: 10.1210/en.2014-1374.

PMID:
25343273
13.

Up-regulation of neogenin-1 increases cell proliferation and motility in gastric cancer.

Kim SJ, Wang YG, Lee HW, Kang HG, La SH, Choi IJ, Irimura T, Ro JY, Bresalier RS, Chun KH.

Oncotarget. 2014 May 30;5(10):3386-98.

14.

Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer.

Kim SJ, Hwang JA, Ro JY, Lee YS, Chun KH.

Oncotarget. 2013 Sep;4(9):1461-71.

15.

Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis.

Lee EW, Kim JH, Ahn YH, Seo J, Ko A, Jeong M, Kim SJ, Ro JY, Park KM, Lee HW, Park EJ, Chun KH, Song J.

Nat Commun. 2012;3:978. doi: 10.1038/ncomms1981.

PMID:
22864571
16.

Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression.

Wang YG, Kim SJ, Baek JH, Lee HW, Jeong SY, Chun KH.

Exp Mol Med. 2012 Jun 30;44(6):387-93. doi: 10.3858/emm.2012.44.6.044.

17.

Over-expression of miR-145 enhances the effectiveness of HSVtk gene therapy for malignant glioma.

Lee SJ, Kim SJ, Seo HH, Shin SP, Kim D, Park CS, Kim KT, Kim YH, Jeong JS, Kim IH.

Cancer Lett. 2012 Jul 1;320(1):72-80. doi: 10.1016/j.canlet.2012.01.029. Epub 2012 Jan 21.

PMID:
22269208
18.

MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.

Kim SJ, Shin JY, Lee KD, Bae YK, Sung KW, Nam SJ, Chun KH.

Breast Cancer Res. 2012 Jan 18;14(1):R14.

19.

Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1).

Kim SJ, Shin JY, Lee KD, Bae YK, Choi IJ, Park SH, Chun KH.

PLoS One. 2011;6(9):e25103. doi: 10.1371/journal.pone.0025103. Epub 2011 Sep 22.

20.

Galectin-3 germline variant at position 191 enhances nuclear accumulation and activation of β-catenin in gastric cancer.

Kim SJ, Shin JY, Cheong TC, Choi IJ, Lee YS, Park SH, Chun KH.

Clin Exp Metastasis. 2011 Dec;28(8):743-50. doi: 10.1007/s10585-011-9406-8. Epub 2011 Jul 13.

PMID:
21750908

Supplemental Content

Loading ...
Support Center